Amy Brodtmann

Professor Amy Brodtmann is a leading academic in neuroscience and cognitive health at Monash University's School of Translational Medicine. She has held senior roles including Co-Head of Behavioural Neuroscience at the Florey Institute and Honorary Professorships. Her research focuses on dementia, stroke, and neurodegenerative diseases with over $35M in NHMRC grants. She leads multidisciplinary teams and clinical trials, contributing to high-impact journals like Neurology and The Lancet Neurology.

• Education: PhD in Neuroscience from University of Melbourne (2004)
• Affiliations: Victorian Heart Institute, Florey Institute of Neuroscience and Mental Health, Eastern Cognitive Disorders Clinic

Her research spans biomarkers (e.g., neurofilament light chain), clinical trials (e.g., MR-CASPER stroke trial), and health equity in Indigenous populations. She has received the Mervyn Eadie Award for mid-career excellence and chairs international advisory boards. Her team includes 10 researchers and collaborates across disciplines, including AI-driven imaging and driver safety for dementia patients.

Teaching roles include weekly clinical sessions for neurology trainees and coordinating cognitive training programs. She actively participates in global initiatives like ENIGMA and ISGC, advancing stroke recovery and cognitive biomarker research.